drugset / Trial / NCT00647751
Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan's lamotrigine 25 mg tablets to GlaxoSmithKline's (GSK) Lamictal® 25 mg tablets following a single, oral 50 mg (2 x 25 mg) dose administration under fed conditions.
Timeline
- Start
- 2004-08
- Primary completion
- 2004-08
- Completion
- 2004-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lamotrigine | Small molecule | 50 mg | Oral |
Indications
No indication recorded.